Sanofi Reallocates Capital to Myeloid Platforms as the Patent Cliff Looms
Sanofi invests significantly in immune-system medicines.
Sanofi invests significantly in immune-system medicines.
Viking Therapeutics is preparing for significant developments in biopharmaceuticals.